VKTX
Viking Therapeutics Inc.
$32.37
+$1.99(+6.55%)
50
Overall
60
Value
60
Tech
31
Quality
Market Cap
$3.44B
Volume
1.28M
52W Range
$22.96 - $43.15
Target Price
$91.88
Company Overview
| Mkt Cap | $3.44B | Price | $32.37 |
| Volume | 1.28M | Change | +6.55% |
| P/E Ratio | -9.6 | Open | $30.52 |
| Revenue | -- | Prev Close | $30.38 |
| Net Income | $-359.6M | 52W Range | $22.96 - $43.15 |
| Div Yield | N/A | Target | $91.88 |
| Overall | 50 | Value | 60 |
| Quality | 31 | Technical | 60 |
No chart data available
Latest News
Analysts Offer Insights on Healthcare Companies: Incyte (INCY), Nuvalent (NUVL) and Viking Therapeutics (VKTX)
Brian Anderson•13 days ago
Viking Therapeutics Shareholders Back Board, Pay, and Auditor
TipRanks Auto-Generated Newsdesk•a month ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VKTX | $32.37 | +6.6% | 1.28M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Viking Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW